{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/blepharitis/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"fd79cb69-88c9-53b3-a6a8-4bc9d0b0848f","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 5ec79617-7476-4470-ba8c-bbeecda2c344 --><h2>Changes</h2><!-- end field 5ec79617-7476-4470-ba8c-bbeecda2c344 -->","summary":null,"htmlStringContent":"<!-- begin item acca7960-12cd-4e1d-9512-137d1c6dd7d5 --><!-- begin field 5c7354a5-e780-4012-9118-306e02333b75 --><p><strong>April 2019</strong> — reviewed. A literature search was conducted in April 2019 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. No major changes to clinical recommendations have been made.</p><!-- end field 5c7354a5-e780-4012-9118-306e02333b75 --><!-- end item acca7960-12cd-4e1d-9512-137d1c6dd7d5 -->","topic":{"id":"210e4b01-890a-5a0a-a3cf-efcece1eb08e","topicId":"1bba37b4-ec1b-49d5-acc1-6fc1671711cf","topicName":"Blepharitis","slug":"blepharitis","lastRevised":"Last revised in April 2019","chapters":[{"id":"b93c0a0c-4692-53c9-843f-49ee05545451","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"9c38019b-31fa-5b39-9bb8-b27769998a9b","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"9620e929-162c-539c-b063-b0d2d792fc78","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"fd79cb69-88c9-53b3-a6a8-4bc9d0b0848f","slug":"changes","fullItemName":"Changes"},{"id":"ccbb8929-8463-57af-b3d5-cf785a546c74","slug":"update","fullItemName":"Update"}]},{"id":"4111c3c7-ee03-523b-800b-280e6b45dfbf","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"aff6bd9c-9a5d-5a90-9983-0fb81983feba","slug":"goals","fullItemName":"Goals"},{"id":"ec8eea31-e7ad-50f8-a443-eb9120f2bd11","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"7d5547f8-0c93-5d41-9cd4-d98e71ef7975","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4e0b92f2-dd2a-568f-9ce8-bfcc52e4599d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"960b987f-d9f7-5a39-8b20-715ba8988e6b","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"250fbd5e-7fdf-5849-bf02-a9c794a764ef","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"44811d5c-7af7-54f4-8fbe-e23a28523234","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"09fc8800-1ae4-546d-be0b-62e044edfca1","slug":"definition","fullItemName":"Definition"},{"id":"6899ed96-f696-5938-9656-d097419cff77","slug":"causes","fullItemName":"Causes"},{"id":"9a08c813-358a-52ed-8317-6734ad0caa2c","slug":"prevalence","fullItemName":"Prevalence"},{"id":"9261cec2-b5d4-5c5d-9e32-4a0d9acc38cb","slug":"prognosis","fullItemName":"Prognosis"},{"id":"48fb1bb9-46aa-5515-a112-656b86a86a56","slug":"complications","fullItemName":"Complications"}]},{"id":"3916f955-e558-5e75-911e-ae48f8579e84","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"c59566b4-f12c-545c-8941-a7de38155871","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"23eadfb4-a45e-50b5-9d14-0f785ac86a84","slug":"assessment","fullItemName":"Assessment"},{"id":"a1f19a88-0a61-5514-b729-f6ba8636d70e","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"aa038862-8424-552a-84d0-e962619a7e33","fullItemName":"Management","slug":"management","subChapters":[{"id":"a41dab9c-d988-5d7a-813e-2d7a1658f5bc","slug":"management-of-blepharitis","fullItemName":"Scenario: Management of blepharitis"}]},{"id":"e0741730-0deb-5ab5-9f8a-0113b66dbe06","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"48e19546-bded-5436-9f23-e37a6fc78e36","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"b75f0439-fc4c-5236-954c-bfe59f6da9a5","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b6a215d3-627d-577f-ba63-d0387c86ce0e","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"78dfcd62-db19-57fc-8f1f-0a100d3e4268","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"8e70896c-9149-59b5-b395-aa848fcd9ab2","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"4289ac7a-ea00-51b4-8b87-184e9a519291","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"28ab262f-aac6-5c78-badf-72aa21ca0119","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"9620e929-162c-539c-b063-b0d2d792fc78","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"5cba5d69-2b8f-5b2d-8d3a-1af018618a82","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field 48438780-a095-4840-b57e-281008797a97 --><h3>Previous changes</h3><!-- end field 48438780-a095-4840-b57e-281008797a97 -->","summary":null,"htmlStringContent":"<!-- begin item 84390003-541d-4454-83f0-58a233ff4c9c --><!-- begin field 7c912b9c-aa52-4a00-b436-e5f4f435d224 --><p><strong>October 2015</strong> — reviewed. A literature search was conducted in October 2015 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. No changes to clinical recommendations have been made.</p><p><strong>September 2012</strong> — reviewed. A literature search was conducted in September 2015 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomised controlled trials (RCTs) published since the last revision of the topic. No changes to clinical recommendations have been made</p><p><strong>April 2011</strong> — minor update. Change to recommendation regarding need for additional contraception during or after a course of tetracycline — additional contraception is no longer required when using antibiotics that are not enzyme inducers with combined hormonal methods for durations of 3 weeks or less. Issued in June 2011.</p><p><strong>March 2011</strong> — topic structure revised to ensure consistency across CKS topics — no changes to clinical recommendations have been made.</p><p><strong>September 2010</strong> — minor update. Hydromoor® (hypromellose 0.3% preservative-free single dose eye drops) have been included. Issued in September 2010.</p><p><strong>March 2010</strong> — minor update. Lubri-Tears® eye ointment has been discontinued. Prescription removed. Issued in March 2010.</p><p><strong>December 2007 to May 2008</strong> — converted from CKS guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence.</p><ul><li>The clinical scenario structure has been reviewed.</li><li>There have been changes to the oral antibiotic prescriptions offered. Lymecycline has been added to the list of recommended tetracyclines.</li><li>Dosing recommendations for the tetracyclines have been amended; a higher initial dose is recommended for 4 weeks, followed by a lower maintenance dose for a further 8 weeks.</li><li>Prescriptions of amoxicillin and erythromycin to treat acute staphylococcal infection (cellulitis) have been removed because this indication is now outside the scope of this CKS topic. In recognition of this, the age threshold has been increased to 10 years as chronic blepharitis is very rare in young children.</li></ul><p><strong><strong>January 2006</strong></strong> — minor update. Black triangle removed from carmellose sodium eye drops. Issued in February 2006.</p><p><strong>October 2005</strong> — minor technical update. Issued in November 2005.</p><p><strong>August 2004</strong> — reviewed. Validated in November 2004 and issued in April 2005.</p><p><strong>August 2001</strong> — reviewed. Validated in November 2001 and issued in April 2002.</p><p><strong>August 1998</strong> — written.</p><!-- end field 7c912b9c-aa52-4a00-b436-e5f4f435d224 --><!-- end item 84390003-541d-4454-83f0-58a233ff4c9c -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}